期刊文献+

创新科技和信息化时代血管外科研究领域的现状和展望 被引量:6

Current status and perspectives of researches in the field of vascular surgery in the era of innovation, technology and informatics
原文传递
导出
摘要 实验研究和临床研究在血管外科的发展中起重要推动作用,随着创新科技和信息化的高速发展,在血管外科研究领域机遇和挑战并存.本文概述了临床医学相关研究模式的推进,并从转化医学、比较效益研究、精准医学和大数据角度,阐述近几年血管外科研究在这些领域的研究进展,内容涵盖干细胞移植治疗肢体严重缺血的转化和临床研究;新材料、新器械及三维打印技术的应用;血管外科常见疾病的比较效益研究包括腹主动脉瘤及颈动脉疾病的开放手术和微创的腔内血管外科手术比较;下肢动脉闭塞性病变治疗中不同球囊支架材料的比较;基因多型性和药物动力学;基因异常与血管病变及有意义的使用数据.各类研究的根本目的都是更好地服务于人类健康. Both basic and clinical researches play important roles in the advancement of vascular surgery.Along with the rapid progress in innovation,technology and informatics,chances and challenges are coexisting.We briefly described the evolution of the research models related to clinical medicine.From the perspective of translational medicine,comparative effectiveness research,precision medicine and big data,we reviewed the recent researches in the field of vascular surgery,which covers translational and clinical researches of stem cell transplantation for the treatment of critical limb ischemia;the application of new materials,devices,equipment and 3D printing;comparative studies of most common vascular diseases including open surgical versus minimally invasive endovascular treatment of abdominal aortic aneurysm,and carotid artery disease,as well as comparisons of efficacy of different balloons or stents used for the treatment of peripheral artery disease;gene polymorphism and pharmacodynamics;genetic abnormalities and vascular diseases.Regardless of the research,the ultimate purpose is to provide the better care to the human being.
作者 蒋米尔 黄英
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2016年第5期1174-1178,共5页 Chinese Journal of Experimental Surgery
关键词 血管外科 转化医学 精准医学 大数据 Vascular surgery Translational medicine Precision medicine Big data
  • 相关文献

参考文献30

  • 1黄官梦茜,蒋米尔,黄英,李维敏,陆信武,黄新天,陆民.氧化低密度脂蛋白对巨噬细胞的作用及机制[J].中华实验外科杂志,2015,32(1):63-66. 被引量:4
  • 2蒋米尔,赵振.动脉粥样硬化实验研究的热点与展望[J].中华实验外科杂志,2014,31(4):699-701. 被引量:9
  • 3黄英.美国梅奥医学中心CTSA临床转化培训的体会和思考[M]//戴克戎.转化医学:理念、策略与实践.第一版.西安:第四军医大学出版社,2012:137-147.
  • 4Psaltis PJ, Simari RD. Vascular wall progenitor ceils in health and dis- ease [ J ]. Circ Res,2015,116 ( 8 ) : 1392-1412. DOI : 10.1161/circresaha. 116. 305368.
  • 5Mohamed Omer S, Krishna SM, Li J, et al. The efcacy of extraembry- onic stem ceils in improving blood flow within animal models of lower limb ischaemia [ J ]. Heart,2016,102 ( 1 ) :69-74. DOI : 10.1136/heartjnl-2015-308322.
  • 6Compagna R, Amato B, Massa S, et al. Cell therapy in patients with critical limb ischemia[ J]. Stem Cells Int,2015 ,2015 :931420. DOI : 10.1155/2015/931420.
  • 7Peeters Weem SM, Teraa M, den Ruijter HM, et al. Quality of life after treatment with autologous bone marrow derived cells in no option severe lirab ischemia[ J]. Eur J Vase Endovasc Surg,2016,51 ( 1 ) :83-89. DOI : 10. 1016/j. ejvs. 2015.09. 010.
  • 8Ma Q, Xia X, Tao Q, et al. Profound actions of an agonist of growth hormone-releasing hormone on angiogenic therapy by mesenchymal stem ceils [ J ]. Arterioscler Thmmb Vase Biol, 2016,36 ( 4 ) : 663- 672. DOI:10. ll61/atvbaha. 116. 307126.
  • 9Kim JE, Jung KM, Kim SH, et al. Combined treatment with systemic and local delivery of substance P coupled with self-assembled peptides for a hind limb ischemia model[ J]. Tissue Eng Part A ,2016,22(5- 6) :545-555. DOI : 10. 1089/ten. TEA. 2015. 0412.
  • 10Koch JM, D' Souza SS,Schwahn D J, et al. Mesenchymoangioblast-de- rived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlirah ischemic injury in mice[J]. Cytotherapy,2016,18(2) :219-228. DOI: 10. 1016/j. jcyt. 2015.10. 013.

二级参考文献43

  • 1Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke sta- tistics-2014 update:a report from the american heart association[ J]. Circulation ,2014,129 ( 3 ) : e28-e292.
  • 2Sima AV,Stancu CS, Simionescu M. Vascular endothelium in athero- sclerosis[ J]. Cell Tissue Res,2009,335 ( 1 ) : 191-201.
  • 3Huo Y, Weber C, Forlow SB, et al. The chemokine KC,but not mono- cyte chemoattractant protein-1, triggers monocyte arrest on early ather- osclerotic endothelium [ J]. J Clin Invest, 2001,108 ( 9 ) : 1307-1314.
  • 4Weber C, Weber KS, Klier C,et al. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H) 1 -like/CD45 RO ( + ) T ceils[ J ] Blood ,2001,97 (4) : 1144-1146.
  • 5Schober A, Manka D, wm Hundelshausen P, et al. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury[ J]. Circu- lation,2002,106 ( 12 ) : 1523-1529.
  • 6Dorgham K,Ghadiri A, Hermand P,et al. An engineered CX3CR1 antagonist endowed with anti-inflammatory activity [ J ]. J Leukoc Bi- o1,2009,86(4) :903-911.
  • 7Liehn EA,Piccinini AM, Koenen RR, et al. A new monocyte chemo- tactic protein-1/chemokine CC motif ligand-2 competitor limiting neointima formation and myocardial ischemia/reperfusion injury in mice [ J ]. J Am Coil Cardiol, 2010,56 ( 22 ) : 1847-1857.
  • 8Gilbert J,Lekstrom-Himes J,Donaldson D,et al. Effect of CC chemo- kine receptor 2 CCR2 blockade on serum C-reactive protein in indi- viduals at atherosclerotic risk and with a single nucleotide polymor- phism of the monocyte chemoattractant protein-I promoter region[ Jl. Am J Cardio1,2011,107 (6) :906-911.
  • 9SchNer N, Langer C, Dhner H, et al. Serum microRNAs as a novel class of biomarkers : a comprehensive review of the literature [ J ]. Exp Hemato1,2010,38 (12) : 1126-1130.
  • 10Stein JJ, Iwuchukwu C, Maier KG, et al. Thrombospondin-l-induced vascular smooth muscle cell migration and proliferation are functional- ly dependent on mieroRNA-21 [ J. Surgery,2014,155(2 ) :228-233.

共引文献11

同被引文献42

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部